Our mission at Precision Neuroscience is to develop and commercialize brain-computer interfaces (BCI). We are pursuing minimally invasive approaches to BCI to address major unmet clinical needs. We are well-capitalized and have an IP portfolio that has been built over nearly 10 years. Brain-computer interfaces represent a new frontier in medicine and computing. We seek to establish Precision Neuroscience as one of the leading companies in this space globally. Our core objective is to deliver life-changing technology to millions of patients worldwide, and in doing so to transform the ways we interact with machines, one another, and our world.